BioCatalyst

CRBP — Corbus Pharmaceuticals Holdings, Inc. catalysts

1 verified catalyst event(s) for Corbus Pharmaceuticals Holdings, Inc. (ticker CRBP). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-11-01 — First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor. · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-01
in 4mo
ESTIMATED
 READOUT
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Phase 1/2 · Solid Tumor
 CRBP Corbus Pharmaceuticals Holdi CRB-601 monoclonal antibody, Anti-PD-1 m ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.